Abstract
The etiopathology of Alzheimer’s disease (AD) is extremely complex and heterogeneous, often associated withcomorbidities. As a result it may be unlikely that AD may be mitigated by drug acting on a single specific target. The currenttendency in drug design and discovery in AD is the rational design or “serendipitous” discovery of new drug entitieschallenging multiple targets. Since two of the presently approved drugs for AD are based on natural products (galantamineand the physostigmine-derivative rivastigmine), many plants are now under investigation as a potential source of newdrugs. Multifunctional drugs often have their origin in natural sources. This review is limited to plant chemicals havingdifferent targets with actual (galantamine) or promising (drugs from Crocus sativus, Ginkgo biloba, Salvia species, andHuperzia serrata) clinical evidence in people with dementia or AD.
Keywords:Alzheimer’s disease, cholinergic system, crocus sativus, drug discovery and development, galantamine, ginkgobiloba, huperzia serrata, multitargets, nicotine, nAChR, plant drug, salvia species, systems biology
Current Medicinal Chemistry
Title:Multitarget Drugs of Plants Origin Acting on Alzheimer's Disease
Volume: 20Issue: 13
Author(s):P. Russo, A. Frustaci, A. Del Bufalo, M. Fini and A. Cesario
Affiliation:
Keywords:Alzheimer’s disease, cholinergic system, crocus sativus, drug discovery and development, galantamine, ginkgobiloba, huperzia serrata, multitargets, nicotine, nAChR, plant drug, salvia species, systems biology
Abstract: The etiopathology of Alzheimer’s disease (AD) is extremely complex and heterogeneous, often associated withcomorbidities. As a result it may be unlikely that AD may be mitigated by drug acting on a single specific target. The currenttendency in drug design and discovery in AD is the rational design or “serendipitous” discovery of new drug entitieschallenging multiple targets. Since two of the presently approved drugs for AD are based on natural products (galantamineand the physostigmine-derivative rivastigmine), many plants are now under investigation as a potential source of newdrugs. Multifunctional drugs often have their origin in natural sources. This review is limited to plant chemicals havingdifferent targets with actual (galantamine) or promising (drugs from Crocus sativus, Ginkgo biloba, Salvia species, andHuperzia serrata) clinical evidence in people with dementia or AD.
Export Options
About this article
Cite this article as:
Russo P., Frustaci A., Del Bufalo A., Fini M. and Cesario A., Multitarget Drugs of Plants Origin Acting on Alzheimer's Disease, Current Medicinal Chemistry 2013; 20 (13) .https://dx.doi.org/10.2174/0929867311320130008
DOI https://dx.doi.org/10.2174/0929867311320130008 | Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher | Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the Treatment of Chronic Inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for manyyears. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium,tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. Thecontinuing interest in ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
- Vascular Contribution to Alzheimer Disease: Predictors of Rapid Progression
CNS & Neurological Disorders - Drug TargetsCardiovascular Complications in Inflammatory Bowel Disease
Current Drug TargetsTraditional Chinese Medicine - Sea Urchin
Mini-Reviews in Medicinal ChemistryDiagnostic Strategy for Suspected Unilateral Absence of the Pulmonary Artery
Current Medical ImagingDaily Melatonin Administration Attenuates Age-Dependent Disturbances of Cardiovascular Rhythms
Current Aging Science Potential Options to Treat Hypertriglyceridaemia
Current Drug Targets Genetic and Molecular Determinants of Atherosclerotic Plaque Instability
Current Vascular Pharmacology Endothelin Receptor Antagonists: A New Therapeutic Option for Improving the Outcome after Solid Organ Transplantation?
Current Vascular PharmacologyPercutaneous Coronary Intervention Associated with a Higher Riskof Hypoxemia and COVID-19 Severity
Current Medicinal ChemistryA Comprehensive Review on Perfusion Method Development for Bone Marrow Collection and Stem Cell Transplantation
Current Stem Cell Research & TherapyMarkers of Early Vascular Ageing
Current Pharmaceutical Design NAD in Skin: Therapeutic Approaches for Niacin
Current Pharmaceutical Design Pharmacological Manipulation of Brain Glycogenolysis as a Therapeutic Approach to Cerebral Ischemia
Mini-Reviews in Medicinal Chemistry Alzheimers Disease, Ceramide, Visfatin and NAD
CNS & Neurological Disorders - Drug TargetsApplication of G-CSF in Congestive Heart Failure Treatment
Current Cardiology ReviewsLipases in Medicine: An Overview
Mini-Reviews in Medicinal ChemistryPDE-5 Inhibitors: Clinical Points
Current Drug TargetsCoarctation of the Aorta - The Current State of Surgical and Transcatheter Therapies
Current Cardiology Reviews Vascular Effects of Antiarrhythmic Drugs and the Roles of K+ Channels
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Reactive Oxygen Species, Nitric Oxide and Hypertensive Endothelial Dysfunction
Current Hypertension Reviews
[8]ページ先頭